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Abstract
Mass drug administration (MDA) programmes against Onchocerca volvulus use ivermectin (IVM) which targets microfilariae
(MF), the worm’s offspring. Most infected individuals are hyporesponsive and present regulated immune responses despite
high parasite burden. Recently, with MDA programmes, the existence of amicrofilaridermic (a-MF) individuals has become
apparent but little is known about their immune responses. Within this immunoepidemiological study, we compared
parasitology, pathology and immune profiles in infection-free volunteers and infected individuals that were MF+ or a-MF.
The latter stemmed from villages in either Central or Ashanti regions of Ghana which, at the time of the study, had received
up to eight or only one round of MDA respectively. Interestingly, a-MF patients had fewer nodules and decreased IL-10
responses to all tested stimuli. On the other hand, this patient group displayed contrary IL-5 profiles following in vitro
stimulation or in plasma and the dampened response in the latter correlated to reduced eosinophils and associated factors
but elevated neutrophils. Furthermore, multivariable regression analysis with covariates MF, IVM or the region (Central vs.
Ashanti) revealed that immune responses were associated with different covariates: whereas O. volvulus-specific IL-5
responses were primarily associated with MF, IL-10 secretion had a negative correlation with times of individual IVM therapy
(IIT). All plasma parameters (eosinophil cationic protein, IL-5, eosinophils and neutrophils) were highly associated with MF.
With regards to IL-17 secretion, although no differences were observed between the groups to filarial-specific or bystander
stimuli, these responses were highly associated with the region. These data indicate that immune responses are affected by
both, IIT and the rounds of IVM MDA within the community. Consequently, it appears that a lowered infection pressure due
to IVM MDA may affect the immune profile of community members even if they have not regularly participated in the
programmes.
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Introduction
Infections with Onchocerca volvulus commence with the transmis-
sion of larvae by biting vector hosts (black flies) [1,2]. Female
filariae create and dwell within subcutaneous nodules called
onchocercomas [3,4] whereas male worms do not take up
permanent residency but migrate in the subcutaneous tissue
between nodules inseminating numerous females [4]. Over an
average of 10 years, females produce millions of offspring,
microfilariae (MF), which primarily reside in the skin for 12–18
months [4,5,6]. The most severe disease manifestations are not
usually induced by adult worms but elicited by the death of MF
passing through the skin and corneas: this leads to various
manifestations of dermatitis, and decreases in visual capacity may
ultimately lead to blindness [1,7,8]. Through mass drug admin-
istration (MDA) programmes, cases of river blindness are
PLOS Neglected Tropical Diseases | www.plosntds.org 1 February 2014 | Volume 8 | Issue 2 | e2679
becoming more scarce but despite this good news .102 million
people remain at risk and the impact of dermal manifestations on
daily life should not be underestimated [9,10]. Currently,
ivermectin (IVM) remains the only drug which is recommended
for MDA regimes but it targets MF and has not much, if any,
effect on adult worms [11]. Research on the endosymbiotic
relationship between the bacteria Wolbachia and filariae, has
revealed that doxycycline therapy targets and destroys the bacteria
[12,13]. Since Wolbachia are essential for the worms’ fertility and
survival, this treatment constitutes the only safe macrofilaricidal
mechanism [5,14].
O. volvulus-infected individuals who reside in areas that have
received none or only a few rounds of MDA present a spectrum of
disease symptoms with two polar forms, generalized onchocerciasis
(GEO) or sowda. GEO or hyporesponsive individuals have
palpable nodules under their skin but no strong pathology despite
carrying high MF skin loads [15]. Patients with severe pathology
on the other hand are termed hyperreactive or sowda [16,17].
Histological assessment of nodules allows one to decipher between
previously interrupted transmission (mainly aged worms past the
time of fecundity) and females with pre-formed embryos but no
developed MF [18]. Thus, despite being elicited by the same
parasite, the range of clinical manifestations is quite broad and
such diversity is thought to reflect the intensity and type of host
immune responses to the parasite, its products, the Wolbachia [5]
and even anti-helmintic therapy. With regards to the latter, in
hyperendemic areas that have received multiple rounds of IVM, a
further group of individuals have been reported. These patients
have adult worms and nodules but are microfilariae negative and
display little pathology. Since this type of scenario is uncommon in
onchocerciasis infection without interference by IVM treatment, it
is now hypothesised that they stem from MDA indicating that this
patient group is in essence ‘‘man-made’’.
Several studies have elucidated mechanisms and cell types that
are thought to play a role in modulating immune responses in filaria-
infected individuals. Amongst them are regulatory T cells (Treg), IL-
10 producing Tr1 cells, alternatively activated macrophages (AAMs)
and the immuno-modulatory capacity of Wolbachia, especially on
innate cells [19,20,21,22,23,24]. As mentioned above, hyporespon-
sive patients are considered to have a regulated immune system and
are characterized by high levels of IL-10, Treg populations, and
IgG4 [16,17,20,24]. The latter is known to be induced by Treg and
to be a poor inducer of antibody-dependent cell-mediated
cytotoxicity (ADCC) since it cannot fix complement and binds
rather weakly to effector cell Fc receptors [17,25,26,27]. Since IgG4
binds to the same receptor as IgE, it has been hypothesized that
elevations of this immunoglobulin prevent overt immune responses.
Indeed, sowda patients portray quite the opposite picture in that
they have dominant Th2 responses, high levels of IgE and
eosinophilia and very few worms [28]. This is also reflected in
nodule pathology [6,29]. Most immunological studies have focused
on comparing hyporeactive (MF+) with sowda and exposed but non-
infected individuals termed endemic normals (EN). Interestingly,
when compared to hyporeactive patients, EN display stronger
antigen-specific proliferation and a mixed Th1/Th2 dichotomy
[24,30,31,32]. To date however, very little is known about the final
population who are amicrofilaridermic (a-MF) [33,34]. These
patients are actually a dead end for the parasite since the lack of
MF limits transmission. Moreover, if current theories are correct,
this population is thought to stem from repeated IVM therapy.
Within this study, we took an in-depth look at filarial-specific and
bystander immune responses in infection-free volunteers, MF+ and
a-MF individuals. Patients lacking MF showed elevated numbers of
neutrophils but dampened eosinophilia and associated factors in the
periphery, reduced pathological parameters and IL-10 responses
but elevated O. volvulus-specific IL-5 responses. Moreover, using
multivariable regression analysis, unique immune aspects of infected
individuals were found to be highly correlated with either the
presence of MF or ivermectin intake on both personal and
community based levels.
Materials and Methods
Study population and ethics statement
In 2009, we examined a cohort of 210 O. volvulus infected
individuals that resided in 24 villages adjacent to the river Offin in
Ghana (Upper and Lower Denkyira Districts in the Central
Region and the Amansie Central and Adanse South Districts in
the Ashanti Region). These rain forest areas are within vector
range (,12 km), are hyperendemic for onchocerciasis but not
other filarial infections and were not part of either OCP or APOC
programmes. MDA has been implemented by the Ghanaian
Ministry of Health since 2001 in Upper and Lower Denkyira
districts and from 2008 in the Amansie and Adanse South areas.
However, MDA compliance has not been overly effective,
especially in the Upper and Lower Denkyira districts, and
therefore, at the time of sampling a considerable number of
people had not or not frequently taken part in IVM therapy. Men
and women (18–55) in the cohort were recruited as part of the
study entitled ‘‘Comparison of doxycycline alone vs doxycycline
plus rifampicin in their efficacy against onchocerciasis’’ registered
with Current Control Trials as ISRCTN68861628 (http://www.
controlled-trials.com/ISRCTN68861628/hoerauf). Participants
also completed a study questionnaire about their medical history
which included a section about the number of times they had
taken IVM and this information was checked, when possible,
against reports provided by community health workers and
distributors. All individuals had at least one nodule and the entire
study group had, on average, an individual IVM intake (IIT) of
1.5. In the four months prior to sampling, 4 patients had taken
IVM and at the time of sampling 2/4 were MF+. Of note, the data
Author Summary
Onchocerciasis affects over 37 million people in poor
communities. Infected individuals usually present a gen-
eralized form which is characterized by low inflammation,
tightly-controlled immune responses and high parasite
burden. In contrast, patients with chronic dermatitis
(sowda) have reduced parasite loads and severe pathol-
ogy. Current disease control is based on mass drug
administration (MDA) with ivermectin (IVM) which mainly
eliminates microfilariae (MF), the transmission life-stage. In
hyperendemic areas, 95% of individuals are MF+, whereas
in hypoendemic areas the rate is ,30%. Recently, in areas
that have been part of MDA programmes, individuals have
been identified that present nodules but are amicrofilar-
idermic (a-MF). The following study therefore compared
immunological profiles of a-MF and MF+ individuals and
determined that only a handful of parameters significantly
differed. Multivariable regression analysis revealed that
immune responses were correlated to covariates MF, IVM
or even the residing area (implying differing rounds of IVM
MDA). For example, IL-5 responses were highly associated
with MF whereas IL-17 responses were related to the
region. The data imply that this ‘‘man-made’’ group has a
distinct immune profile but also suggests that immune
responses are affected by the amount of IVM intake on
both the individual and community level (region).
Immune Profiling of Amicrofilardermic O. Volvulus Individuals
PLOS Neglected Tropical Diseases | www.plosntds.org 2 February 2014 | Volume 8 | Issue 2 | e2679
presented here were performed before the patients started any
treatment the trial protocol is referring to. Ethical clearance,
including immunological studies, was given by the Committee on
Human Research Publication and Ethics at the University of
Science and Technology in Kumasi, Ghana, the ethics committee
at the University of Bonn, Germany and the Liverpool School of
Tropical Medicine, UK. For comparison, samples were collected
from 12 infection-free volunteers. These volunteers resided in non-
rural areas of the same districts and are thus classified here as non-
endemic normals (NEN). Written informed consent was obtained
from all individuals.
Parasitological assessment
All infected patients presented at least one palpable nodule [35].
For MF analysis, two skin biopsies of 1–3 mg were taken from the
buttocks using a corneoscleral (Holth) punch (Koch, Hamburg,
Germany). Each biopsy was immersed in 100 ml of 0.9% NaCl
solution in a well of a microtiter plate (Nunc, Roskilde, Denmark).
The skin biopsies were incubated overnight at room temperature
to allow MF to emerge. The solution was then transferred onto a
slide for microscopic examination [14,36]. The biopsies were
weighed using a Sartorius electronic balance (Go¨ttingen, Ger-
many) and MF load was calculated per mg skin. Blood smears
from all patients were screened for their cellular compositions and
malaria infections using standard Giemsa staining protocols. The
presence of further helminth infections were assessed using
standard diagnostic tests on stool and urine samples [37].
Antigens and antibodies
A soluble extract of Onchocerca volvulus worm antigen (OV) was
prepared as previously described [20] and extracts of Brugia malayi
female worms were prepared from infected jirds that were or were
not treated with tetracycline (BmFE and BmFEtet, [38]).
Recombinant peptidoglycan-associated lipoprotein (wPAL) and
Wolbachia surface protein (WSP) were prepared as previously
described [38,39]. LPS (Serratia marescens) was obtained from
Sigma-Aldrich (Taufkirchen, Germany) and tuberculin purified
protein derivative (PPD) from Statens Serum Institute (Copenha-
gen, Denmark). Anti-CD3 and anti-CD28 antibodies were
purchased from eBiosciences (Frankfurt, Germany). Polymyxin B
sulphate salt (P4932) and secondary antibodies for IgG1-4 were
obtained from Sigma-Aldrich, whereas that for IgE was purchased
from Southern Biotech (Birmingham, USA).
Assessment of O. volvulus-specific IgE and IgG subclasses
Individual plasma samples were screened for the content of
filarial-specific IgE and IgG1-4. In brief, 96-well polysorb plates
(Nunc, Roskilde, Denmark) were coated overnight at 4uC with
5 mg/ml O. volvulus extract in PBS (pH 9.6). Plates were washed 3
times in 0.05% Tween/PBS (pH 7.2) and once with PBS alone.
Plates were then blocked with 200 ml/well of 1% BSA/PBS for
two hours at room temperature. After an additional washing step,
50 ml/well of diluted plasma was added in triplicate (1:500 for
IgG1-4 and 1:20 for IgE) and incubated overnight at 4uC. After
washing, 50 ml/well of biotinylated secondary antibodies were
added for two hours at room temperature, IgG1 (1:1,000), IgG2
(1:15,000), IgG3 (1:4,000), IgG4 (1:15,000); IgE (1:1,000).
Following the next wash, 50 ml/well streptavidin-peroxidase
(Roche Diagnostics, Mannheim, Germany; 1:5,000) was incubated
for 45 minutes at room temperature. After the final wash, 50 ml/
well of substrate solution containing TMB (tetramethylbenzidine,
Sigma-Aldrich) was used and the reaction was stopped with 25 ml/
well 2N H2SO4 (Sigma-Aldrich). The plates were measured using
the SpectraMAX ELISA reader (Molecular Devices, Sunyvale,
U.S.) with wavelength correction (450 nm and 570 nm). Data
were analyzed with SOFTmax Pro 3.0 software. Pooled plasma
from 15 patients was used to generate standard calibration curves
which were assigned arbitrary units. This standard was used for
each measurement of anti-filarial antibodies. In plasma from
healthy European donors O. volvulus-specific IgG1-4 and IgE were
not detectable (data not shown).
PBMC preparation and in vitro cell cultures
PBMCs were isolated as previously described [37]. Plasma
samples were frozen at 220uC until further required. Cell
suspensions were washed twice with sterile PBS (8 min at 4006
g room temperature) and re-suspended in RPMI 1640 medium
(PAA, Linz, Austria), supplemented with 10% FCS, 2 mM L-
glutamine, 50 mg/ml penicillin/streptomycin and 50 mg/ml gen-
tamicin (all PAA) before determining the cell concentration with
trypan blue (Sigma-Aldrich). Thereafter, 26105 PBMCs/well
were plated onto 96-well plates (U-shaped, Greiner Bio-One,
Frickenhausen, Germany). PBMCs were then left either un-
stimulated or stimulated in triplicate with the following stimuli:
OV (5 mg/ml), BmFE (5 mg/ml), BmFEtet (5 mg/ml), anti-CD3/
anti-CD28 (10 mg/ml and 2.5 mg/ml respectively), LPS (50 ng/
ml), PPD (10 mg/ml), wPAL and WSP (both at 5 mg/ml in
combination with 50 mg/ml of Polymyxin B). Cultures containing
Polymyxin B alone elicited only background cytokine responses
(data not shown). Cultures were incubated for 72 hours at 37uC in
5% CO2. Supernatants were collected and frozen until further use.
Cytokine measurements
Culture supernatants from stimulated PBMCs were thawed on
ice and analyzed for the content of IL-5, IL-6, IL-10, IL-13, IL-17,
IFN-c and TNF using R&D Duo sets (R&D Systems, Wiesbaden-
Nordenstadt, Germany) in accordance with the manufacturer’s
instructions. The plates were measured and analyzed as
mentioned above.
Analysis of IL-5 and ECP levels in plasma samples
Undiluted plasma samples from infected patients were analyzed
for the content of IL-5 (Quantikine, R&D Systems) and eosinophil
cationic protein (ECP) (Aviscera Bioscience, Inc, Santa Clara,
USA) according to the manufacturer’s instructions. The plates
were measured and analyzed as mentioned above.
Statistical analysis
Statistical analyses were performed using the software SPSS
(IBM SPSS Statistics 20; Armonk, NY), the PRISM 5 programme
(GraphPad Software, Inc., La Jolla, USA) and SAS version 9.2
(SAS Institute Inc. Cary, NC, USA). Since most of the variables
did not show a normal distribution, the following tests were
chosen: to compare three groups a Kruskal-Wallis-test was
performed and, if significant, followed by a Mann-Whitney–U
test for a further comparison of the groups; for comparisons of two
binary variables the Fisher’s exact test and for comparisons of
continuous parameters the Spearman correlation was used. The
immune response data were also assessed using a generalized
linear model. Initially, parameters including age, gender, nodules
and co-infections were included as covariates but the relevant
associations were revealed with regional, IVM and MF related
parameters. Therefore, a more stringent analysis was conducted
using the covariates ‘‘times of individual IVM therapy (IIT)’’,
‘‘IVM intake within the last 12 months’’, ‘‘MF-positivity’’ and
‘‘microfilarial density’’. In addition, we included a regional
covariate, ‘‘Central:Ashanti’’, since at the time of sampling,
Immune Profiling of Amicrofilardermic O. Volvulus Individuals
PLOS Neglected Tropical Diseases | www.plosntds.org 3 February 2014 | Volume 8 | Issue 2 | e2679
villages in the Central region had had 7 years of MDA whereas
those in the Ashanti region had only had programmes for 1 year.
This covariate consisted of 14 villages (82 individuals) from the
‘‘Central’’ region and 10 villages (128 individuals) from the
‘‘Ashanti’’ region. For this model continuous variables were rank-
transformed. If more than one covariate was below p,0.1
following univariable analysis, a further multivariable stage was
conducted (p,0.05).
Results
Clinical evaluation of Onchocerca volvulus infected
patients
Within the study population described here, 22% of the infected
individuals were amicrofilaridermic despite all presenting at least
one nodule (which constituted an inclusion criterion for the study).
164 individuals were MF+ with a range from 0.06–330.81 MF/mg
skin. With regards to further worm infections 8.5% MF+ (14/164)
and 8.7% a-MF (4/46) individuals were co-infected with either
hookworms (n = 13), Schistosoma mansoni (n = 2) or S. haematobium
(n = 4). We determined whether the absence of MF was associated
with the number of nodules and sites since these parameters reflect
the amount and tissue distribution of adult worms. Upon
comparison with a-MF individuals, microfilaridermic patients
displayed significantly more sites and nodules (Figures 1A and B
respectively). In addition, the amount of microfilariae positively
correlated with both of these parameters (MF and nodules:
r = 0.231, p = 0.001 and MF and sites: r = 0.317, p,0.001).
Filarial-specific antibody levels remain unaltered in a-MF
individuals
Hyporesponsive individuals generally display increased levels of
filarial-specific IgG4 [7,17,40]. Thus, we compared O. volvulus-
specific Ig profiles in NEN, MF and a-MF individuals and as
expected filarial-specific antibody levels were significantly in-
creased in infected individuals (Table 1). However, when
comparing Ig levels in the two infected populations, no differences
could be observed in any of the measured parameters especially
IgE (Figure 2A) and IgG4 (Figure 2B). Moreover, the ratio of
IgG4/IgE was also not significantly altered between both groups
(date not shown). Of note, MF load in MF+ individuals positively
correlated to some IgG subclasses (IgG4: r = 0.161, p = 0.040
(Figure 2C), IgG1: r = 0.171, p= 0.029 and IgG3; r = 0.165,
p = 0.036 (data not shown).
Elevated eosinophils and associated factors in MF+
individuals
Eosinophilia is a common characteristic of helminth infections
and the balance between eosinophils and neutrophils has been
shown to be correlated with the survival of cattle filaria, Onchocerca
ochengi [41]. To observe whether a-MF individuals displayed
altered peripheral cell differentiation, blood smears were assessed
for neutrophils (Figure 3A) and eosinophils (Figure 3B), macro-
phages and lymphocytes (data not shown). With regards to
macrophages and lymphocytes, no differences were observed
between the two groups. a-MF patients did however present
significantly higher numbers of neutrophils (Figure 3A) but less
eosinophils (Figure 3B) which were negatively correlated with one
another (Figure S1A, p.0.001; r =20.511). Moreover, in infected
patients, levels of eosinophils were positively correlated with MF
load (Figure S1B), which was not the case with neutrophils (Figure
S1C). Further indications of elevated eosinophil activity in MF+
individuals was reflected in their increased amounts of plasma
bound ECP (Figure 3C), a ribonuclease superfamily member that
has helmintho-toxic properties [42]. Activated eosinophils are not
only drawn to IL-5 but produce it themselves and plasma levels of
this cytokine were also significantly elevated in MF+ patients
(Figure 3D). Next, we analyzed levels of IL-5 and another Th2
cytokine, IL-13, in culture supernatants of PBMCs that were
stimulated with either aCD3/aCD28 (Figures 4A and C), or
filarial antigen preparations (Figures 4B and D). Here, three
different antigen preparations were employed: OV (a preparation
of adult O. volvulus worms), BmFE (an extract of B. malayi female
adult worms) and BmFEtet (female B. malayi adults that had been
Figure 1. O.volvulus infections are characterized by the presence of nodules in the skin.MF+ (n = 164) and amicrofilaridermic (a-MF, n = 46)
individuals were examined for the number of sites (A) and the number of nodules (B) by palpation. Graphs show box whiskers with median,
interquartile ranges and outliers. As indicated, statistical significances between the groups were obtained using Mann-Whitney tests.
doi:10.1371/journal.pntd.0002679.g001
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harvested from infected animals that had been treated with a
tetracycline). Since the administration of such antibiotics leads to
the depletion of Wolbachia, the latter antigen was used to determine
whether the absence of this bacteria altered immune responses
[38,43,44]. All infected patients showed elevated IL-5 and IL-13
responses when stimulated with aCD3/aCD28 but no differences
were observed between the two infected groups (Figure 4A and C
respectively). In contrast to the situation found in plasma, PBMCs
from a-MF individuals produced significantly higher amounts of IL-
5 when exposed to an OV extract (Figure 4B). Interestingly, this
significance was lost when the antigen extract stemmed from a
related filarial species (Figure 4B). Filarial-specific IL-13 responses
were low and no differences were observed between MF+ and a-MF
patients with any of the tested filarial antigens. However, PBMCs
from MF+ individuals reacted better to OV and BmFE than
BmFEtet indicating that either the absence ofWolbachia reduced this
Th2 response, or that tetracycline treatment also reduced bona fide
filarial antigens that contained T cell epitopes (Figure 4D).
Elevated levels of IL-10 in patently infected patients
High levels of IL-10 have been described in onchocerciasis
patients presenting the hyporeactive form of infection
[7,16,17,24,45]. To analyze whether IL-10 responses were altered
in a-MF individuals, isolated PBMCs were stimulated with either
aCD3/aCD28 (Figure 5A) or filarial antigen preparations
(Figures 5B–D). As depicted in Figure 5, all infected patients
produced significantly higher amounts of IL-10 when compared to
responses of PBMCs isolated from NEN. Moreover, when
compared to a-MF patients, PBMCs from MF+ individuals had
significantly stronger IL-10 responses upon exposure to all three
filarial extracts (Figures 5B–D). These dominant IL-10 profiles in
MF+ individuals were further emphasized after assessing the ratio
of IL-10/IL-5 levels, which were significantly higher in MF+ than
in a-MF patients (Figure 5E). Alongside Th2 cytokines and IL-10
(Figures 4 and 5 respectively), we also measured levels of IFN-c
and IL-17 (Figure S2). Here, no significant differences could be
observed between the groups and this was independent of the
applied stimulus: aCD3/aCD28 (Figures S2A and E) or filarial
extracts (Figures S2B–D, F–H). In addition, we also screened
immune profiles to bystander antigens such as PPD (Figure S3) or
LPS (Figures S4). When compared to NEN, IL-10 responses
became elevated regardless of the tested stimuli (Figures S3G and
S4G). Moreover, PPD stimulated cell cultures from a-MF patients
contained significantly less IL-10 when compared to responses
from MF+ individuals (Figure S3G). Interestingly, no significant
differences in Th-related cytokines were detected between the
infected groups upon triggering cells with LPS (Figure S4).
Filarial-specific up-regulation of innate cytokines in
infected individuals
After observing alterations in Th immune responses we
addressed whether pro-inflammatory responses were also skewed
in a-MF patients. Upon LPS stimulation infected groups showed
Figure 2. Lack of dermal residing MF does not alter filarial-specific antibody profiles. Plasma samples from all participants (NEN, MF+ and
a-MF) were investigated for the presence of filarial-specific Igs by ELISA. Plates were coated overnight with 5 mg/ml O. volvulus worm extract.
Thereafter, levels of IgE (A) and IgG4 (B) were detected in all individual samples diluted 1:20 and 1:500 respectively. Data are depicted as absolute
values expressed in arbitrary units [AU]. Graphs show box whiskers with median, interquartile ranges and outliers. Statistical significances between
the indicated groups were obtained after Kruskal-Wallis and Mann-Whitney tests. Data in (C) show the correlation of dermal MF with the amount of
filarial-specific IgG4; determined using the Spearman correlation test.
doi:10.1371/journal.pntd.0002679.g002
Table 1. O. volvulus-specific Ig levels of study participants
shown as median and range.
NEN (n=12) MF+ (n = 164) a-MF (n=46)
IgG1 [AU] 0.00 [0.00, 0.06] 0.25 [0.00, 9.72] 0.22 [0.00, 2.35]
IgG2 [AU] 0.00 [0.00, 2.70] 0.24 [0.07, 1.52] 0.28 [0.08, 1.26]
IgG3 [AU] 0.00 [0.00, 0.09] 0.17 [0.00, 3.27] 0.18 [0.00, 2.59]
IgG4 [AU] 0.00 [0.00, 0.11] 0.29 [0.00, 1.49] 0.26 [0.00, 1.58]
IgE [AU] 0.03 [0.00, 0.13] 0.27 [0.00, 1.90] 0.34 [0.00, 2.01]
Plasma samples from all participants (NEN, MF+ and a-MF) were investigated for
the presence of O. volvulus-specific Igs by ELISA. Data are depicted as absolute
values expressed in arbitrary units [AU]. Values show median and range.
doi:10.1371/journal.pntd.0002679.t001
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significantly elevated levels of both IL-6 and TNF but no
significant differences were observed between the two groups
(Figures S4E and F). The same pattern was observed after
measuring responses to PPD (Figures S3E and F). With regards to
filarial-specific extracts, both infected groups showed elevated IL-6
responses following stimulation with OV and interestingly, these
responses were significantly stronger than those elicited to BmFE
and BmFEtet (Figure 6A), indicating that these reactions were
mediated by components specific to O. volvulus. When compared to
responses from NEN, TNF responses from both infected groups
were also significantly elevated using OV or BmFE extracts
(Figure 6B). Using the preparation of BmFEtet however, levels
were no longer significant and PBMCs from NEN also began to
respond (Figure 6B). Since these data indicated that the removal of
Wolbachia decreased TNF responses we further analyzed PBMC
responses using two Wolbachia-specific stimuli: Peptidoglycan-
associated lipoprotein (wPAL) and Wolbachia surface protein
(WSP). When compared to responses from NEN, PBMCs from
infected patients produced elevated levels of IL-6 (Figures 7A and
B) and TNF (Figures 7C and D) in response to wPAL and WSP.
Moreover, when compared to responses from MF+ patients, a-MF
individuals produced significantly less TNF in response to wPAL
(Figure 7C).
Multivariable regression analysis indicates that immune
responses are associated with MF or ivermectin therapy
on both the individual and community level
As described above, in many of the immunological parameters
no significant differences could be observed between MF+ and a-
MF individuals. However, a-MF patients did present a reduced
amount of nodules (Figure 1) and decreased IL-10 responses to
both filarial-specific and bystander stimuli (Figure 5, S3G, S4G).
In addition, this group of individuals showed stronger IL-5
responses to OV antigens in vitro (Figure 4A) but reduced IL-5,
eosinophils and ECP in plasma (Figure 3). The occurrence of a-
MF patients is considered to be the result of repeated IVM
treatment and/or missing re-infections [33]. Thus, we analyzed
Figure 3. Decreased levels of eosinophils and eosinophil-associated proteins in a-MF patients. O. volvulus infected participants were
investigated for the percentages of neutrophils (A) and eosinophils (B) using standard Giemsa stained blood smears. In addition, the presence of ECP
(C) and IL-5 (D) were determined in plasma samples by ELISA. Graphs show box whiskers with median, interquartile ranges and outliers. Statistical
significances between the indicated groups were obtained after Mann-Whitney tests.
doi:10.1371/journal.pntd.0002679.g003
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the number of individual IVM treatments (IIT) in our infection
groups and as expected, a-MF patients had received IVM more
often when compared to microfilaridermic patients (Figure 8A).
Although age was increased in the former group (Figure S5A),
there was no significant correlation between age and IIT (Figure
S5B). However, there was a significant negative correlation
between the amount of MF and times of individual IVM therapy
(Figure 8B r=20.482). To gain insight into whether the previous
intake of ivermectin on an individual level or the frequency of
IVM distribution within the community was influencing the
immunological profile of a-MF patients we performed a multi-
variable regression analysis which included the variables ‘‘MF-
positive’’, ‘‘MF/mg’’, ‘‘times of individual IVM therapy (IIT)’’,
‘‘IVM in the last 12 months’’ and ‘‘Central:Ashanti’’. The latter
refers to a regional-based covariate which consisted of 14 villages
(82 individuals) from the ‘‘Central’’ region and 10 villages (128
individuals) from the ‘‘Ashanti’’ region. As mentioned above, at
the time of sampling, MDA programmes had run 7 years longer in
the Central region. Since our entire cohort had, on average, an
individual IVM intake of 1.5 doses, any dominant associations
between immune responses and the regional covariate indicate
that this may result from the rounds of IVM within the community
and in turn, lowered transmission rates. Table 2 shows a synopsis
of the variables that were correlated with a particular immune
response (right), and following multivariable analysis the factor
that had the highest correlation (far right column). In many cases,
the regression analysis supported the data shown in the above
figures. For example, levels of IL-5 that were released upon re-
stimulation with OV antigen had a negative correlation with MF/
mg which confirms the differences that were observed between
MF+ and a-MF individuals (Fig. 4B). Although not previously
significant (Fig. 5B), IL-5 responses to Bm-derived antigens were
also negatively correlated with MF/mg. In contrast and also in line
with the immune profiles of a-MF patients was the result with in
situ (plasma) levels of IL-5 since these results were highly associated
with MF/mg (c.f. with Fig. 3D). Indeed, all in situ parameters were
highly correlated to MF related covariates. Surprisingly, many IL-
17 or pro-inflammatory responses were more associated with the
regional covariate and in each situation the cytokine production of
PBMCs isolated from individuals in the Central region was lower
Figure 4. Elevated filarial-specific IL-5 production is associated with MF status. Isolated PBMCs (26105/well) from NEN or O. volvulus
infected MF+ or a-MF patients were stimulated with either anti-CD3/anti-CD28 (10 mg/ml/2.5 mg/ml) (A and C), an O. volvulus extract (OV, 5 mg/ml), a
B. malayi female extract (BmFE, 5 mg/ml) or an extract from B. malayi females worms from infected animals that were depleted of Wolbachia through
tetracycline treatment (BmFEtet, 5 mg/ml) (B and D) for 72 hours. Thereafter, levels of IL-5 (A and B) and IL-13 (C and D) were measured in the culture
supernatants via ELISA. Data are plotted as fold increase over unstimulated controls. Graphs show box whiskers with median, interquartile ranges and
outliers. Statistical significances between the indicated groups were obtained after Kruskal-Wallis and Mann-Whitney tests.
doi:10.1371/journal.pntd.0002679.g004
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than those from patients in the Ashanti region. In more detail, with
the exception of responses to OV antigen, all other IL-17
responses were associated with the region. This was also true for
IL-6 responses apart from reactions to BmFEtet antigen which
were negatively correlated to IIT instead. This covariate was also
the most associated factor in the release of TNF to BmFEtet.
Another novel association was the finding with WSP or WPAL
antigens since these too were highly associated with the region and
this was the only covariate to be associated with either TNF and
IL-6 secretion to WSP. Finally, the most interesting outcome of the
regression analysis was the finding with IL-10 responses. For
example, whereas OV and BmFEtet responses were highly
associated with IIT, BmFE responses were related to the presence
of MF and aCD3/aCD28 and LPS responses were most strongly
associated with the region. These results highlight the fact that the
broad spectrum suppression of IL-10 responses in a-MF individ-
uals was actually influenced by different factors.
Discussion
After comparing 58 measured parameters, the main significant
differences between MF+ and a-MF individuals were seen in
Figure 5. Elevated IL-10 levels in microfilaridermic patients. Isolated PBMCs (26105/well) from NEN or O. volvulus infected MF+ or a-MF
patients were stimulated with either anti-CD3/anti-CD28 (A), OV (B), BmFE extract (C) or BmFEtet extract (D) for 72 hours. Thereafter, levels of IL-10
were measured in the culture supernatants via ELISA. (E) shows the ratios of IL-10/IL-5 for each stimuli. Data are plotted as fold increase over
unstimulated controls. Graphs show box whiskers with median, interquartile ranges and outliers. Statistical significances between the indicated
groups were obtained after Kruskal-Wallis and Mann-Whitney tests.
doi:10.1371/journal.pntd.0002679.g005
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classical hallmarks of O. volvulus infections: number of nodules, in
situ (plasma) levels of IL-5, ECP and eosinophils and O. volvulus-
specific IL-10 responses after stimulation in vitro. Moreover, using
multivariable regression analysis our data suggests that MF or
IVM therapy (on either an individual or community level) can
differently influence certain immune parameters. Moreover, the
data provides initial evidence that in response to diverse stimuli the
secretion of a single cytokine (IL-10) from the same individual can
be influenced by different factors. Of note, although both groups
of patients displayed strong filarial-specific immunoglobulin levels
no differences were observed. This is in agreement with other
longitudinal studies that have shown no variations in Ig levels after
several years of MDA [34]. Since both infected groups here were
hyporesponsive (GEO), this result was somewhat anticipated and
actually strengthens the differences that we and others have found
between GEO and sowda patients. That is, high IL-10 and IgG4
in GEO individuals compared to high IgE, elevated Th2 responses
and severe pathology in sowda patients [4,9,17,29,46]. This type
of immune-regulation in GEO patients conforms with their
increased worm burden and MF loads since high levels of IgG4
would counter-regulate IgE and therefore dampen overt responses
to helminths [47]. Moreover, IgG4 is thought to aid MF survival
by adhering to MF and preventing ADCC reactions elicited by
other Ig subclasses and positive correlations were observed
between IgG4 and MF in this study [48,49]. To an extent the
data from the regression analysis supports this hypothesis since
there was a strong association of IgG4 with the region (Table 2)
and as mentioned before, individuals from the Ashanti region had
higher levels of MF than those residing in Central districts.
IL-10 is considered an immunosuppressive modulator acting on
a number of innate and adaptive immune cells and deletion of the
IL-10 gene can render mice more susceptible to infection
pathology or autoimmune disease [50]. Humans display a
substantial inter-individual variability and the intensity of IL-10
secretion has been linked to inherited polymorphisms [51].
Interestingly, Timman et al. determined that certain promoter
haplotypes of IL-10 influence filarial-specific proliferation respons-
es of PBMC from O. volvulus individuals [45] which correlates with
Figure 6. Increased O. volvulus-specific IL-6 and TNF responses in infected individuals. Isolated PBMCs (26105/well) from NEN or O.
volvulus infected MF+ or a-MF patients were stimulated with either OV extract, BmFE extract or BmFEtet extract. After 72 hours, levels of IL-6 (A) and
TNF (B) were measured in the culture supernatants via ELISA. Data are plotted as fold increase over unstimulated controls. Graphs show box whiskers
with median, interquartile ranges and outliers. Statistical significances between the indicated groups were obtained after Kruskal-Wallis and Mann-
Whitney tests.
doi:10.1371/journal.pntd.0002679.g006
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Figure 7. Induction of innate cytokines by Wolbachia-derived antigens. Isolated PBMCs (26105/well) from NEN or filarial infected MF+ or a-
MF patients were stimulated with either wPAL (5 mg/ml) (A and C) or WSP (5 mg/ml) (B and D), for 72 hours. Thereafter, levels of IL-6 (A and B) and
TNF (C and D) were measured in the culture supernatants via ELISA. Data are plotted as fold increase over unstimulated controls. Graphs show box
whiskers with median, interquartile ranges and outliers. Statistical significances between the indicated groups were obtained after Kruskal-Wallis and
Mann-Whitney tests.
doi:10.1371/journal.pntd.0002679.g007
Figure 8. Individual IVM therapy is higher in a-MF+ individuals. Infected individuals completed a study questionnaire which included a
section about the number of times they had taken IVM (IIT). The data are displayed as box whiskers with median, interquartile ranges and outliers (A).
Statistical significances between the indicated groups were obtained after Mann-Whitney tests and significant differences are indicated in the figures.
IIT was then correlated to the amount of skin residing microfilariae (B). Correlations were determined using the Spearman correlation test.
doi:10.1371/journal.pntd.0002679.g008
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studies showing that IL-10 neutralization reverses hypo-responsive
T cells ex vivo [24]. Although such findings provide insight into
genetic predispositions that could determine the outcome of
infection, the analysis performed in our current study demonstrat-
ed that all infected patients produced more IL-10 upon classical T
cell activation or filarial-specific re-stimulation. Interestingly, when
compared to MF+ individuals, a-MF patients produced signifi-
cantly less IL-10 to both filarial-specific and bystander stimuli (LPS
and PPD). Moreover, following regression analysis it was revealed
that IL-10 responses to different stimuli had varying correlations.
For example, whereas responses to OV and BmFEtet had a
negative correlation to IIT, responses to BmFE were highly
associated with the presence of MF. Although the cellular source
of IL-10 in filarial-infected patients remains undetermined it has
been demonstrated that on average 75% of T cells, 10% B cells,
8% CD14+ monocytes and 7% NK cells produce IL-10 in
response to filarial specific re-stimulation [52]. Moreover, even
though a substantial proportion of these CD4+IL-10+ T cells made
Table 2. Summary of regression analysis between MF+ and a-MF patients.
Parameter Stimulus Associations with Univariable analysis Multivariable analysis
aCD3/aCD28 MF/mg*, IVM 12 months** —
IL-5 OV MF/mg**, MF+**, IVM 12 months** MF/mg (neg. correlation, p,0.001)
BmFE MF/mg**, MF+* MF/mg (neg. correlation, p = 0.017)
BmFEtet MF/mg**, MF+* MF/mg(neg. correlation, p = 0.004)
IL-13 aCD3/aCD28 MF/mg**, MF+* —
aCD3/aCD28 C:A**, MF+*, IVM 12 months** C:A (CQAq, p = 0.013)
OV C:A**, MF+**, IIT** IIT (neg. correlation, p = 0.011)
IL-10 BmFE MF+**, IIT** MF-positive (posqnegQ, p = 0.005)
BmFEtet MF+**, IIT** IIT (neg. correlation, p = 0.003)
PPD C:A*, MF+**, IIT* —
LPS C:A**, MF+*, IIT* C:A (CQAq, p = 0.016)
OV C:A (CQAq, p = 0.001) nd
BmFEtet IIT (neg. correlation, p = 0.014) nd
IL-6 wPAL C:A**, IVM 12 months** C:A (CQAq, p,0.001)
WSP C:A(CQAq, p = 0.007) nd
PPD C:A**, IVM 12 months** C:A (CQAq, p = 0.001)
LPS C:A**, MF+*, IVM 12 months** C:A (CQAq, p = 0.015)
BmFE IIT**, IVM 12 months** —
BmFEtet IIT (neg. Correlation, p = 0.02) nd
TNF wPAL C:A**, MF+** C:A (CQAq, p = 0.01)
WSP C:A(CQAq, p = 0.038) nd
LPS C:A**, MF+* —
aCD3/aCD28 C:A**, MF/mg**, MF+**, IIT**, IVM 12 months** C:A (CQAq, p,0.001)
IL-17 OV C:A*, IIT** —
BmFEtet C:A**, IIT*, IVM 12 months* C:A (CQAq, p = 0.01)
PPD C:A**, MF+* C:A (CQAq, p = 0.017)
LPS C:A**, IIT**, IVM 12 months** C:A (CQAq, p = 0.001)
IFN-c PPD MF-positive (posQnegq, p = 0.032)
In situ (plasma)
IgE — nd
IgG4 C:A(CQAq, p = 0.036) nd
IL-5 MF/mg**, MF+**, IIT**, IVM 12 months** MF/mg (pos. correlation, p,0.001)
Neutrophils MF/mg*, MF+**, IIT* MF-positive (posQnegq, p = 0.02)
Eosinophils MF/mg**, MF+**, IIT** MF/mg (pos. correlation, p,0.001)
ECP MF/mg**, MF+** MF/mg (pos. correlation, p,0.001)
C:A denotes the Central:Ashanti regional covariate. IIT denotes the number of times an individual had received IVM therapy.
*denotes p,0.1.
**denotes p,0.05.
‘nd’ denotes that only one covariate was below p,0.1 and therefore no multivariable analysis was done. ‘—’ denotes that no dominant factor was found in the
multivariable analysis. Data were assessed using a generalized linear model analysis using the parameters ‘‘IIT’’, ‘‘IVM intake within the last 12 months’’, ‘‘MF-positivity’’,
‘‘microfilarial density - Mf/mg’’ and ‘‘Central:Ashanti’’ as covariates. The latter denotes a regional distribution covariate consisting of 14 villages (82 participants) in the
Central region and 10 villages (128 individuals) in the Ashanti region. If more than one covariate had a p,0.1 following univariate analysis (depicted in italics), a further
multivariable stage was conducted in order to identify the highest correlating factor.
doi:10.1371/journal.pntd.0002679.t002
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IL-4 but not IFN-c, the majority produced neither [52] and this
correlates with our earlier findings on T cell clones generated from
subcutaneous tissue from patient nodules [20].
In contrast to the suppressed IL-10 responses, PBMCs from our
a-MF infected cohort produced significantly higher levels of IL-5
to OV stimulus and this response was shown to be primarily
associated with MF. Surprisingly however, when compared to
MF+ individuals, circulating levels of IL-5 were significantly
dampened in the a-MF group which was further substantiated in
the multivariable regression analysis: positive correlation with
MF/mg. Our a-MF cohort had viable adult worms and had
received an average of only 2 rounds of IVM and perhaps
therefore, their peripheral responses begin to reflect post patent
individuals (+16 years of IVM therapy), which showed reduced
filarial-specific IL-5 responses [31,34]. This is the first study to
determine opposing cytokine profiles in situ (plasma) and following
stimulation in vitro and depicts how important it is to obtain an
overall picture when trying to determine the immunomodulatory
capacity of helminths. Reduced IL-5 levels in a-MF individuals
were also reflected in the dampened percentage of eosinophils and
amount of ECP but not neutrophils. In O. volvulus infections,
eosinophil infiltration into the nodules is triggered by MF release
and it has been shown that eosinophils actively attack MF. Indeed,
Wildenburg et al. demonstrated that very few eosinophils were
present in nodules that did not contain MF [53]. Eosinophils
function through several factors; ECP for example, is primarily
excreted by degranulating eosinophils and its secretion can be
elicited in an either antibody-dependent or antibody-independent
(complement) manner. Although its anti-helmintic properties
remain unclear it is assumed that ECP works on MF rather than
adult worms [54]. This hypothesis would support our findings that
elevated levels of ECP were observed in MF+ but not a-MF
individuals and all these peripherally-measured parameters were
highly associated with the presence or density of MF. However,
previous studies have shown that sowda patients have even higher
levels of ECP than MF+ patients despite their low levels of MF
[42]. In the studies performed here, IL-5, ECP and eosinophil
number were all positively correlated in MF+ patients. Since these
infection characteristics are also apparent in sowda patients [42]
we conclude that a-MF patients have a unique immune profile in
which neutrophils play a prominent role.
Neutrophils have been a rather neglected cell population but
numerous pieces of research are beginning to reveal a see-saw
relationship between eosinophils and neutrophils during filarial
infections. Studies have shown that both eosinophils and
neutrophils increased shortly after IVM therapy with the former
being strongly associated with MF elimination within the draining
lymph nodes [55,56]. Our data shows that neutrophils are
significantly elevated in a-MF patients even after a lengthy
interval of individual IVM therapy but according to our regression
analysis it is the presence of MF that is most associated with
neutrophil numbers. Peripheral eosinophils were strongly down-
regulated in a-MF individuals and multivariable regression
analysis revealed that this immune factor had a positive correlation
with the density of MF in the skin. Interestingly, it appears that
nodule-forming Onchocerca spp. can coexist with large numbers of
infiltrating neutrophils for many years without any apparent
impediment to the parasites’ physiology or reproduction and
moreover, such cells may even protect the worm from eosinophil
degranulation. As mentioned above, O. volvulus worms depend on
their endosymbiotic relationship with Wolbachia which reside
within the lateral cords and reproductive apparatus [16]. Indeed,
this essential partnership has provided alternative chemothera-
peutic approaches since elimination of Wolbachia by antibiotic
treatment causes sterility and eventually worm death [14,57]. It
has been shown that neutrophils are attracted to Wolbachia-derived
molecules [58], but following antibiotic chemotherapy they are
replaced by eosinophils that degranulate on the worm cuticle. In a
study with O. ochengi, the filarial parasite of cattle, eosinophil
degranulation was significantly increased following antibiotic but
not conventional adulticidal regimes and was associated with
worm vitality not degeneration [41]. Nevertheless, it remains
unclear during O. volvulus infections whether the influx of
eosinophils is an intentional act to kill the parasite and moreover,
what parasitic or immune scenario they are attracted to.
Much research has focused on elucidating Wolbachia-derived
components that immunomodulate host immune responses. WSP
is a highly conserved Wolbachia surface protein and has been noted
to stimulate innate responses through distinctive TLR family
members [4,38]. WSP has been shown to induce the release of IL-
8 from human neutrophils and has anti-apoptotic effects that are
not mediated through Fas-pathways [59]. Here, we found that
preparations of WSP and wPAL elicited IL-6 and TNF from
infected patients and moreover, TNF levels were reduced in a-MF
individuals. Furthermore, levels of TNF secretion from infected
individuals were reduced when cells were exposed to worm
preparations depleted of Wolbachia. Collectively these data indicate
that a-MF patients have reduced Wolbachia-specific responses.
Similarly, when compared to MF+ individuals, responses to innate
stimuli (LPS) were also weaker in a-MF patients although both
groups of infected patients responded stronger than NEN. The
regression analysis revealed that TNF and IL-6 responses to wPAL
were highly associated with regional distribution and with regards
to WSP this was the only associated covariate. Perhaps such
modulations are related to longer previous IVM MDA in the
Central Region and consequently lower transmission and less
exposure to incoming L3. Since the vast majority of L3 are cleared
by the human host, as a consequence there might be less
Wolbachia-derived signals from perishing L3, which decreases the
responsiveness to Wolbachia. Alternatively the reduced MF load
following IVM in turn decreases the exposure of Wolbachia-derived
signals and therefore the immunomodulatory capacity of such
signals is also reduced.
As with other research on the immune status of O. volvulus-
infected individuals we found very little activity in terms of IFN-c
which was confirmed by the overall lack of association(s) in the
regression analysis. Interestingly, although there were no signifi-
cant differences in IL-17 responses between MF+ and a-MF
individuals, the regression analysis revealed multiple associations
with the regional covariate. For example, with the exception OV
antigen (equally associated with IIT and region), all other IL-17
responses were highly associated with the region. Since IL-17
levels were lower in individuals from the Central region and
moreover people residing in that region had had a higher intake of
IVM in the last 12 months, it indicates that MDA therapy
generates less IL-17 responses or the presence of MF dampens
them. With regards to IL-13, our data partially substantiates the
findings of Brattig et al. [60], since levels were significantly
elevated in infected groups upon aCD3/aCD28 stimulation and
this response was strongly related to the presence of MF. Although
this indicates an elevated Th2 profile, no differences could be
observed between the groups when cells were exposed to either
filarial-specific or bystander stimuli. However, when comparing
the responses of MF+ patients to the different filarial antigens,
responses to Wolbachia depleted antigens were significantly lower.
Differences in immune responses between studies may not only lie
in how helminth antigen extracts are prepared but also in the
experimental study design (whole blood assay versus isolated
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PBMC re-stimulation; since cell concentrations may vary in the
former) or even the amount of antigen added to the cultures and
such aspects require further investigation.
Alongside their unique immune status, a-MF patients also
presented a reduced amount of palpable nodules and sites and this
parameter positively correlated to the number of MF but not the
intake of ivermectin on an individual level (IIT). Introducing a
regional covariate revealed a surprising number of associations
especially IL-17, IL-6 and TNF secretions. Indeed, for some
immune scenarios such as levels of IL-6 in response to OV antigen
or IL-6 and TNF responses to WSP this was the only associated
factor. Moreover, in each situation the cytokine production of
PBMCs isolated from individuals in the Central region was lower
than those from patients in the Ashanti region. Although an a-MF
status in adults may occur in individuals with single sex infections,
in pre-patency or in older patients with aged infertile females, the
experimental data and regression analysis shown here strongly
indicates that these distinct immune profiles stem from three
covariates: MF, IIT and the frequency of IVM distribution within
the community. Moreover, the analysis reveals that the release of
different cytokines by an individual to a certain stimuli can be
dependent on different factors. In conclusion, despite our cohort
having an average individual IVM intake of 1.5, highly significant
associations with the region or frequency of MDA within the
community suggest that a lowered infection pressure due to IVM
MDA may affect community members that have not regularly
participated in MDA programmes, implying that immune
responses are affected by the number of times an individual had
received IVM and the amount of MDA therapy on a community
level. Perhaps such details will help to understand IVM (immune-)
mediated MF killing and also suboptimal performances of IVM
regarding this activity.
Supporting Information
Figure S1 Correlation of neutrophils and eosinophils
with MF. Percentages of eosinophils and neutrophils from
infected individuals were either correlated to each other (A) or
to the amount of skin microfilariae (B and C respectively).
Correlations were determined using the Spearman correlation test.
(TIF)
Figure S2 Filarial antigens induce no alterations in IL-
17 or IFN-c responses. Isolated PBMCs (26105/well) from
NEN or O. volvulus infected MF+ or a-MF patients were stimulated
with either anti-CD3/anti-CD28 (A and E), OV (B and F), BmFE
extract (C and G) or BmFEtet extract (D and H) for 72 hours.
Thereafter, levels of IL-17 (A–D) and IFN-c (E–H) were measured
in the culture supernatants via ELISA. Data are plotted as fold
increase over unstimulated controls. Graphs show box whiskers
with median, interquartile ranges and outliers. Statistical signifi-
cances between the indicated groups were obtained after Kruskal-
Wallis and Mann-Whitney tests.
(TIF)
Figure S3 PPD responses in O. volvulus exposed
individuals. Isolated PBMCs (26105/well) from NEN or O.
volvulus infected MF+ or a-MF patients were stimulated with PPD
(10 mg/ml) for 72 hours. Thereafter, levels of IL-5 (A), IL-13 (B),
IL-17 (C), IFN-c (D), IL-6 (E), TNF (F) and IL-10 (G) were
measured in the culture supernatants via ELISA. Data are plotted
as fold increase over unstimulated controls. Graphs show box
whiskers with median, interquartile ranges and outliers. Statistical
significances between the indicated groups were obtained after
Kruskal-Wallis and Mann-Whitney tests.
(TIF)
Figure S4 Elevated TLR-triggered responses in infected
individuals. Isolated PBMCs (26105/well) from NEN or O.
volvulus infected MF+ or a-MF patients were stimulated with LPS
(50 ng/ml) for 72 hours. Thereafter, levels of IL-5 (A), IL-13 (B),
IL-17 (C), IFN- c (D), IL-6 (E), TNF (F) and IL-10 (G) were
measured in the culture supernatants via ELISA. Data are plotted
as fold increase over unstimulated controls. Graphs show box
whiskers with median, interquartile ranges and outliers. Statistical
significances between the indicated groups were obtained after
Kruskal-Wallis and Mann-Whitney tests.
(TIF)
Figure S5 Relating age and individual IVM therapy
(IIT) in a-MF patients. Within the questionnaire all O. volvulus
infected individuals were asked for their age (A). Graph shows a
scatter plot with median. Statistical significances between the
groups were obtained after Mann-Whitney tests. The number of
times an individual had taken IVM therapy (IIT) was then
correlated to age (B).
(TIF)
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